摘要 |
The invention provides substituted quinoxalines having the general formulas where R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, and R<SUB>4 </SUB>are, inter alia, alkyl, aryl, or heteroaryl groups; Z is NH or O; and X is, inter alia, COOH or CONH<SUB>2</SUB>. The compounds of the invention have antiviral and immunomodulatory activity and are useful for treating infectious diseases, particularly viral infections.
|